文献速递糖尿病

生命第一年感染与高危个体胰岛β细胞自身免疫及临床1型糖尿病的发展:TRIGR队列

Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort.
PubMed 文献 · Diabetologia · 2022-09-09

基于TRIGR队列2159名具有1型糖尿病家族史及HLA易感性的儿童,前瞻性记录生命第一年感染,随访至2017年。调整HLA、性别、母乳喂养时长和出生顺序后,7次及以上感染与至少一种自身抗体阳性相关(HR 9.166),特定细菌感染与临床1型糖尿病风险升高相关(HR 2.066)。作者认为对病毒感染早期启动自身免疫的证据支持较弱。

要点

  • 生命第一年感染≥7次者发生至少一种1型糖尿病相关自身抗体的风险升高(HR 9.166)。
  • 6–12月龄首次病毒感染与至少一种自身抗体阳性风险降低相关(HR 0.828)。
  • 曾发生不明细菌感染者临床1型糖尿病风险升高(HR 2.066)。

核心结论

  • 作者认为对生命早期病毒感染可能启动自身免疫过程或 later 1型糖尿病发展的假设支持较弱。
  • 特定细菌感染似乎增加多种自身抗体和临床1型糖尿病的风险。

研究设计与样本

  • TRIGR队列研究,纳入2159名有一级亲属患病且携带HLA conferred 1型糖尿病易感性的儿童。
  • 2002年至2007年招募,随访至2017年,前瞻性登记感染。
  • 采用单变量和多变量Cox回归模型分析生命第一年感染与自身抗体或临床1型糖尿病的关系。
  • 本研究为探索性,未对多重比较进行调整。

主要发现

  • 调整HLA、性别、母乳喂养时长和出生顺序后,生命第一年感染≥7次者较无感染者更易发生至少一种1型糖尿病相关自身抗体阳性(p=0.028,HR 9.166 [95% CI 1.277, 65.81])。
  • 6–12月龄首次病毒感染与至少一种1型糖尿病相关抗体阳性风险降低相关(p=0.043,HR 0.828 [95% CI 0.690, 0.994]),与多种抗体阳性风险降低相关(p=0.0351,HR 0.664 [95% CI 0.453, 0.972])。
  • 曾发生不明细菌感染者更易发生至少一种1型糖尿病相关自身抗体阳性(p=0.013,HR 1.412 [95% CI 1.075, 1.854])、多种抗体阳性(p=0.037,HR 1.652 [95% CI 1.030, 2.649])及临床1型糖尿病(p=0.011,HR 2.066 [95% CI 1.182, 3.613])。

局限性

  • 本研究为探索性,未对多重比较进行调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Accumulated data suggest that infections in early life contribute to the development of type 1 diabetes. Using data from the Trial to Reduce IDDM in the Genetically at Risk (TRIGR), we set out to assess whether children who later developed diabetes-related autoantibodies and/or clinical type 1 diabetes had different exposure to infections early in life compared with those who did not. METHODS: A cohort of 2159 children with an affected first-degree relative and HLA-conferred susceptibility to type 1 diabetes were recruited between 2002 and 2007 and followed until 2017. Infections were registered prospectively. The relationship between infections in the first year of life and the development of autoantibodies or clinical type 1 diabetes was analysed using univariable and multivariable Cox regression models. As this study was exploratory, no adjustment was made for multiple comparisons. RESULTS: Adjusting for HLA, sex, breastfeeding duration and birth order, those who had seven or more infections during their first year of life were more likely to develop at least one positive type 1 diabetes-related autoantibody (p=0.028, HR 9.166 [95% CI 1.277, 65.81]) compared with those who had no infections. Those who had their first viral infection aged between 6 and 12 months were less likely to develop at least one positive type 1 diabetes-related antibody (p=0.043, HR 0.828 [95% CI 0.690, 0.994]) or multiple antibodies (p=0.0351, HR 0.664 [95% CI 0.453, 0.972]). Those who had ever had an unspecified bacterial infection were more likely to develop at least one positive type 1 diabetes-related autoantibody (p=0.013, HR 1.412 [95% CI 1.075, 1.854]), to develop multiple antibodies (p=0.037, HR 1.652 [95% CI 1.030, 2.649]) and to develop clinical type 1 diabetes (p=0.011, HR 2.066 [95% CI 1.182, 3.613]). CONCLUSIONS/INTERPRETATION: We found weak support for the assumption that viral infections early in life may initiate the autoimmune process or later development of type 1 diabetes. In contrast, certain bacterial infections appeared to increase the risk of both multiple autoantibodies and clinical type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Kordonouri O, Cuthbertson D, Belteky M, et al. Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort. Diabetologia. 2022. PMID: 36083343. doi:10.1007/s00125-022-05786-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。